Companies: 10,795·Total market cap: $144.5T
NewGenIvf Group Limited

NewGenIvf Group Limited

NIVFNASDAQHealthcare● Active
$0.55
$-0.09(-14.51%)
Market Cap$310031
P/E Ratio
52W High$618
52W Low$0.51

NewGenIvf Group Limited (NIVF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

nivf · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for NewGenIvf Group Limited (NIVF) measures how much investors pay for each dollar of the company's trailing earnings. NIVF's current PE ratio of 0.04x is calculated by dividing its stock price of $0.55 by its TTM earnings per share of $15.56. −92.8% discount vs 5Y avg 0.5x

0.04x
P/E Ratio (TTM)92.8%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
0.12x
FY2026 est. EPS $4.74
Based on 1 analyst
EPS (TTM)
$15.56
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NewGenIvf Group Limited SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2021 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 0.5x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Care Facilities · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
NewGenIvf Group Limited
NewGenIvf Group LimitedYou
NIVF
$0M0.04x$15.56
Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited
CCM
$1MN/A-$637.37
CDT Equity Inc.
CDT Equity Inc.
CDT
$4MN/A-$1177.90
Envoy Medical, Inc.
Envoy Medical, Inc.
COCH
$14MN/A-$1.21
Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc.
HEPA
$1MN/A-$0.88
INVO Fertility, Inc.
INVO Fertility, Inc.
IVF
$2MN/A-$199.20
PetVivo Holdings, Inc.
PetVivo Holdings, Inc.
PETV
$22MN/A-$0.41

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
0.49x$16.80
2024-12-31
FY2024
$-0.89
2023-12-31
FY2023
$0.50+276.5%
2022-12-31
FY2022
$1.75
2021-12-31
FY2021
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for NewGenIvf Group Limited (NIVF) measures how much investors pay for each dollar of the company's trailing earnings. NIVF's current PE ratio of 0.04x is calculated by dividing its stock price of $0.55 by its TTM earnings per share of $15.56.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.55 ÷ $15.56 = 0.04x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

NIVF pe ratio · 6 questions

NIVF's current PE ratio is 0.04x as of 2026-06-09, based on a stock price of $0.55 and TTM EPS of $15.56. Data sourced from Financial Modeling Prep via NIVF's SEC 10-K and 10-Q filings.

NIVF PE ratioWhat is NIVF PE ratioCurrent PE ratio of NIVFNIVF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NewGenIvf Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09